KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) EBITDA (2016 - 2025)

Historic EBITDA for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to -$10.5 million.

  • Petmed Express' EBITDA fell 222644.44% to -$10.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$59.0 million, marking a year-over-year decrease of 910778.63%. This contributed to the annual value of $3.6 million for FY2025, which is 21659.05% up from last year.
  • According to the latest figures from Q4 2025, Petmed Express' EBITDA is -$10.5 million, which was down 222644.44% from -$8.4 million recorded in Q3 2025.
  • Petmed Express' 5-year EBITDA high stood at $9.0 million for Q1 2021, and its period low was -$34.1 million during Q2 2025.
  • Its 5-year average for EBITDA is -$709500.0, with a median of $714500.0 in 2023.
  • As far as peak fluctuations go, Petmed Express' EBITDA soared by 107466.67% in 2024, and later crashed by 222644.44% in 2025.
  • Petmed Express' EBITDA (Quarter) stood at $5.9 million in 2021, then plummeted by 97.06% to $172000.0 in 2022, then tumbled by 1887.21% to -$3.1 million in 2023, then surged by 85.36% to -$450000.0 in 2024, then crashed by 2226.44% to -$10.5 million in 2025.
  • Its last three reported values are -$10.5 million in Q4 2025, -$8.4 million for Q3 2025, and -$34.1 million during Q2 2025.